Kestra Medical Technologies, Ltd. Financing Cash Flow
Kestra Medical Technologies, Ltd. (KMTS) reported Financing Cash Flow of $22.50 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. net cash provided by (used in) financing activities for the quarter ending 2026-07-31 was $22.50M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) financing activities for the quarter ending 2026-04-30 was -$185.00K, a 100.09% decline year-over-year.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) financing activities for the quarter ending 2026-01-31 was $149.18M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) financing activities for the quarter ending 2025-10-31 was -$27.00K.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) financing activities for fiscal 2026 was $147.09M, a 55.46% decline from fiscal 2025.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) financing activities for fiscal 2025 was $330.26M, a 324.91% increase from fiscal 2024.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) financing activities for fiscal 2024 was $77.72M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-07-31 | $22.50M 10-Q · filed 2026-09-14 | $22.31M derived: sum of 2 quarters · filed 2026-09-14 | $171.49M derived: sum of 3 quarters · filed 2026-09-14 | $171.47M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | -$185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $149.00M derived: sum of 2 quarters · filed 2026-07-14 | $148.97M derived: sum of 3 quarters · filed 2026-07-14 | $147.09M 10-K · filed 2026-07-14 |
| 2026-01-31 | $149.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $149.16M derived: sum of 2 quarters · filed 2026-03-17 | $147.28M 10-Q · filed 2026-03-17 | $361.98M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | -$1.90M 10-Q · filed 2025-12-11 | $212.80M derived: sum of 3 quarters · filed 2026-09-14 | $212.68M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | -$1.88M 10-Q · filed 2026-09-14 | $212.83M derived: sum of 2 quarters · filed 2026-09-14 | $212.71M derived: sum of 3 quarters · filed 2026-09-14 | $212.13M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $214.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $214.58M derived: sum of 2 quarters · filed 2026-07-14 | $214.01M derived: sum of 3 quarters · filed 2026-07-14 | $330.26M 10-K · filed 2026-07-14 |
| 2025-01-31 | -$119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | -$694.00K derived: sum of 2 quarters · filed 2026-03-17 | $115.56M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | -$575.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | $115.68M 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $116.25M 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | $77.72M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |